The cost-effectiveness core will provide the experience and technical resources to assess cost-effectiveness of the interventions studied or proposed in the Program Project. The CE core will apply the principles of cost-effectiveness analysis, decision modeling, and utility assessment to evaluate the policy implications of changing health beliefs. By providing a unifying paradigm, the CE core will encourage synergies between the component projects by encouraging the adoption of similar data elements, theoretical models, and approaches to design and analysis. The approach to CE analysis includes 6 steps: (1) define the intervention; (2) identify relevant costs; (3) identify relevant effectiveness parameters; (4) measure costs; (5) measure effectiveness; and (6) account for uncertainties. Because trials do not consider all relevant patient populations and do not follow subjects throughout the entire time period of interest, sufficiently comprehensive CE analyses often require extrapolation of future costs and benefits. Decision analysis will be used to make these extrapolations. Decision analysis will also be used to provide normative models; for example, in order to compare current practices regarding estrogen replacement therapy with optimal practices. Utility assessment will provide quantitative representations of patient preferences for health-related outcomes and interventions, as inputs into the calculation of quality-adjusted life years. Members of the CE core have substantial experience in CE analysis, decision modeling, and utility assessment. In addition, the group has practical experience in applying these methodologies in the context of complex multi-disciplinary studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA072099-04
Application #
6203396
Study Section
Project Start
1999-06-01
Project End
2000-05-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Bosworth, H B; Bastian, L A; Kuchibhatla, M N et al. (2001) Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med 63:603-8
Lipkus, I M; Biradavolu, M; Fenn, K et al. (2001) Informing women about their breast cancer risks: truth and consequences. Health Commun 13:205-26
Lipkus, I M; Samsa, G; Rimer, B K (2001) General performance on a numeracy scale among highly educated samples. Med Decis Making 21:37-44
Lipkus, I M; Kuchibhatla, M; McBride, C M et al. (2000) Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev 9:973-5
Halabi, S; Skinner, C S; Samsa, G P et al. (2000) Factors associated with repeat mammography screening. J Fam Pract 49:1104-12
Lipkus, I M; Lyna, P R; Rimer, B K (2000) Colorectal cancer risk perceptions and screening intentions in a minority population. J Natl Med Assoc 92:492-500
McBride, C M; Clipp, E; Peterson, B L et al. (2000) Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 9:418-27
Rimer, B K (2000) Cancer control research 2001. Cancer Causes Control 11:257-70
Ratliff, A; Angell, M; Dow, R W et al. (1999) What is a good decision? Eff Clin Pract 2:185-97
Rimer, B K; Halabi, S; Strigo, T S et al. (1999) Confusion about mammography: prevalence and consequences. J Womens Health Gend Based Med 8:509-20

Showing the most recent 10 out of 12 publications